SCHEMBL6980407

SCHEMBL6980407

CCOC(=O)C=Cc1cc([N+](=O)[O-])ccc1OCCCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 4/20 0.50
AKR1B1 P15121 4/20 0.50
CYP19A1 P11511 3/20 0.48
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
ALOX5 P09917 1/20 0.47
CYP2D6 P10635 1/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 3/20 0.45
TAAR1 Q96RJ0 1/20 0.45
KMT2A Q03164 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
HSP90AA1 P07900 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
CCR6 P51684 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980403 1.00 AKR1B10 (0.50) AKR1B10AKR1B1CYP19A1CYP11B1CYP11B2
SCHEMBL6979703 0.83 FDPS (0.53) AKR1B10AKR1B1ALOX5CYP2D6MAPK1
SCHEMBL6979701 0.83 FDPS (0.53) AKR1B10AKR1B1ALOX5CYP2D6MAPK1
SCHEMBL6980279 0.81 FDPS (0.51) ALDH1A1KMT2ANPSR1MEN1NPC1
SCHEMBL6980282 0.81 FDPS (0.51) ALDH1A1KMT2ANPSR1MEN1NPC1
SCHEMBL6987550 0.79 CYP19A1 (0.59) CYP19A1CYP11B1CYP11B2CYP2D6MAPK1
SCHEMBL13581061 0.78 MAPT (0.47) ALDH1A1KMT2ANPSR1MEN1NPC1
SCHEMBL9078383 0.78 AKR1B10 (0.51) AKR1B10AKR1B1ALOX5LMNAMAPT
SCHEMBL9078388 0.78 AKR1B10 (0.51) AKR1B10AKR1B1ALOX5LMNAMAPT
SCHEMBL6987299 0.78 KMT2A (0.53) ALDH1A1KMT2ANPSR1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-04-24 US disclosed
EP-1292585-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
WO-2001098282-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 2001-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors SQLE, CYP17A1, ACOX1 AKR1B10 227/4885AKR1B1 177/4885CYP19A1 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.